MedAdvisor

MedAdvisor FCF/Debt

Delisted

The Free Cash Flow to Debt Ratio of MedAdvisor (MDR.AX) as of Sep 27, 2026 is -88.83 %. In the previous year, Free Cash Flow to Debt Ratio was 26.60 % — a change of -433.91% (lower).

FCF/Debt

-88.83 %

YoY

-433.91%

Last updated:

Free Cash Flow to Debt Ratio of MedAdvisor is 2026 -88.83 % . Free Cash Flow to Debt Ratio of MedAdvisor was 2025 26.60 % . It decreases by -433.91% lower compared to the previous year.

The MedAdvisor FCF/Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF/Debt
Date
FCF/Debt
Jan 1, 2015
-141.59 AUD
Jan 1, 2020
-633.78 AUD
Jan 1, 2021
-141.20 AUD
Jan 1, 2022
-4.09 AUD
Jan 1, 2023
-12.47 AUD
Jan 1, 2024
26.60 AUD
Jan 1, 2025
-88.83 AUD
The MedAdvisor FCF/Debt history
YEARFCF/DebtYoY
-88.83 %-433.91%
26.60 %-313.33%
-12.47 %+205.22%
-4.09 %-97.11%
-141.20 %-77.72%
-633.78 %+347.61%
-141.59 %—
Access this data via the Eulerpool API

MedAdvisor Stock analysis

What does MedAdvisor do? Medadvisor Ltd is an Australian company that offers a digital platform for healthcare. Founded in 2012 by Robert Read, David Liu, and Josh Swinnerton, their aim was to develop a platform that simplifies medication management for patients, pharmacies, and doctors. Today, Medadvisor is a publicly traded company with a wide range of digital healthcare solutions. They offer various solutions to support patients in medication intake and management, such as a mobile application that allows patients to manage their medications, order prescriptions, and receive reminders. They also offer solutions for pharmacies, including an online ordering system and access to electronic patient history, as well as a platform for doctors to electronically issue prescriptions. One of their latest products is a mobile application that facilitates the handling of COVID-19, providing real-time virus spread tracking and symptom tracking tools. Medadvisor focuses on meeting customer needs and continuously improving the healthcare process. They recently partnered with Take2 Healthcare to expand their range of solutions and create the best offering of health solutions. Overall, Medadvisor plays an important role in the Australian healthcare system by helping their customers live happier and healthier lives through innovative technologies and services. MedAdvisor is one of the most popular companies on Eulerpool.

Frequently Asked Questions about MedAdvisor stock

Free Cash Flow to Debt Ratio of MedAdvisor is -88.83 % in 2026.

Free Cash Flow to Debt Ratio of MedAdvisor changed from 26.60 % to -88.83 %, representing a -433.91% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow to Debt Ratio MedAdvisor since 2006 – with annual values, charts, and detailed analysis.

FCF/Debt measures the percentage of total debt that could be repaid from free cash flow. It is a stricter measure than OCF/Debt as it accounts for capital expenditures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Debt Ratio's MedAdvisor with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — MedAdvisor

All Key Metrics — MedAdvisor